Helping Barry’s Body Beat Cancer with Immunotherapy

When Barry Nelson’s doctors gave him six months to live after a stage III lung cancer diagnosis, he knew he wanted to see a lung cancer specialist, which led him to Dana-Farber/Brigham and Women’s Cancer Center. Nelson joined a clinical trial of an immune checkpoint inhibitor, one of a family of immunotherapy drugs that use the body’s own immune system to fight cancer cells. Today, he is thriving.